Mycophenolate mofetil is an immunosuppressant used primarily to prevent organ rejection in transplant patients, such as kidney, heart, or liver recipients. It works by inhibiting the proliferation of lymphocytes, which are crucial for the immune response. By suppressing the immune system, Mycophenolate mofetil helps the body accept the transplanted organ and reduces the risk of rejection. This medication is essential for improving transplant success rates. In summary, Mycophenolate mofetil is critical for organ transplant management.
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), leading to decreased lymphocyte proliferation and immune response.








